Skip to main navigation

Mobile navigation

Contact Us Portals

Tests

Tests Tests

Tests for Providers

Tests for Providers

Afirma
Genomic Sequencing Classifier Decipher
Prostate Genomic Classifier Decipher
Bladder Genomic Classifier

Prosigna
Breast Risk of Recurrence Test

Discover

Provider Resource Center Scientific Publications Veracyte Diagnostics Platform Clinical Studies

Connect With Us

Ordering Portal Contact Us

Tests for Patients

Cancer Tests

Afirma
Thyroid Nodule Test Decipher
Prostate Cancer Test Decipher
Bladder Cancer Test

Cancer Tests

Prosigna
Breast Cancer Test

Learn

Patient Resource Center Patient Video Stories Frequently Asked Questions

Need Help?

Payment Portal Contact Us

Resources

Resources

Resources For Providers

Resources Centers

Decipher
Prostate Resources Decipher
Bladder Resources Afirma
Thyroid Resources Prosigna
Breast Resources View All →

Explore

Scientific Publications Frequently Asked Questions Video Gallery Document Library Cancer Diagnostic Labs

Connect With Us

Ordering Portal Contact Us

Resources For Patients

Resource Centers

Decipher
Prostate Resources Decipher
Bladder Resources Afirma
Thyroid Resources Prosigna
Breast Resources View All →

Explore

Patient Video Stories Frequently Asked Questions

Connect With Us

Payment Portal Contact Us

Innovation

Technology

Veracyte Diagnostics Platform Clinical Studies Technology & Pipeline

TrueMRD Platform Cancer Diagnostic Labs

Research use only

Afirma GRID Decipher GRID

Innovation Innovation

column Technology

column

column Research use only

Company

About Us

About Veracyte Leadership Careers Working at Veracyte

News & Events

Events & Webinars Press Releases In the News Blog

Connect

Contact Us

Company Company

column About Us

column News & Events

column Connect

Investors

Welcome

Events & Presentations Overview Press Releases

Financials

SEC Filings Quarterly Results Annual Reports Stock Information Analyst Coverage

Governance

Governance Overview Board of Directors Committee Composition Leadership ESG Information

Investor Resources

Investor FAQs Information Request Email Alerts

Investors Investors

column Welcome

column Financials

column Governance

column Investor Resources

Patient Payment Portal
Provider Portal

Tests

Tests for Providers
Afirma
Genomic Sequencing Classifier Decipher
Prostate Genomic Classifier Decipher
Bladder Genomic Classifier

Prosigna
Breast Risk of Recurrence Test

Discover
Provider Resource Center Scientific Publications Veracyte Diagnostics Platform Clinical Studies

Connect With Us
Ordering Portal Contact Us

Cancer Tests
Afirma
Thyroid Nodule Test Decipher
Prostate Cancer Test Decipher
Bladder Cancer Test

Cancer Tests
Prosigna
Breast Cancer Test

Learn
Patient Resource Center Patient Video Stories Frequently Asked Questions

Need Help?
Payment Portal Contact Us
Resources

Resources Centers
Decipher
Prostate Resources Decipher
Bladder Resources Afirma
Thyroid Resources Prosigna
Breast Resources View All →

Explore
Scientific Publications Frequently Asked Questions Video Gallery Document Library Cancer Diagnostic Labs

Connect With Us
Ordering Portal Contact Us

Resource Centers
Decipher
Prostate Resources Decipher
Bladder Resources Afirma
Thyroid Resources Prosigna
Breast Resources View All →

Explore
Patient Video Stories Frequently Asked Questions

Connect With Us
Payment Portal Contact Us
Innovation

Technology
Veracyte Diagnostics Platform Clinical Studies Technology & Pipeline

TrueMRD Platform Cancer Diagnostic Labs

Research use only
Afirma GRID Decipher GRID
Company

About Us
About Veracyte Leadership Careers Working at Veracyte

News & Events
Events & Webinars Press Releases In the News Blog

Connect
Contact Us
Investors

Welcome
Events & Presentations Overview Press Releases

Financials
SEC Filings Quarterly Results Annual Reports Stock Information Analyst Coverage

Governance
Governance Overview Board of Directors Committee Composition Leadership ESG Information

Investor Resources
Investor FAQs Information Request Email Alerts

Press Releases

Items Per Page

Year

Mar 14, 2018

Veracyte Announces New Data Demonstrating “Real-World” Performance of Afirma GSC To Be Presented at ENDO 2018

Read More

Feb 27, 2018

Veracyte Announces Fourth Quarter and Full-Year 2017 Financial Results, Provides 2018 Financial Outlook

Read More

Feb 12, 2018

Veracyte to Host Conference Call and Webcast to Discuss Fourth Quarter and Full-Year 2017 Financial Results on Tuesday, February 27, 2018

Read More

Jan 31, 2018

Veracyte to Present at LEERINK Partners 7th Annual Global Healthcare Conference

Read More

Jan 25, 2018

Veracyte Announces 100,000th Afirma Test Performed to Reduce Unnecessary Surgeries in Thyroid Cancer Diagnosis

Read More

Jan 19, 2018

Veracyte's Chief Science and Medical Officer to Present at The Precision Medicine World Conference

Read More

Jan 18, 2018

Veracyte Announces Publication of Results from Patient Survey Quantifying the Challenges in Diagnosing Interstitial Lung Disease

Read More

Jan 08, 2018

Veracyte Announces Strategic Realignment and New Appointments to Advance Commercial Growth

Read More

Nov 28, 2017

Veracyte Announces Publication of Data Confirming Analytical Validity of Envisia Genomic Classifier for Use in IPF Diagnosis

Read More

Nov 15, 2017

Veracyte to Present at the Piper Jaffray 29th Annual Healthcare Conference

Read More

Pagination

First page
Previous page
…
Page 34
Page 35
Current page 36
Page 37
Page 38
…
Next page
Last page

Displaying 351 - 360 of 549

Contact Investor Relations

Please feel free to contact us if you have questions or would like additional investor relations information:

investors@veracyte.com
+1 619.393.1545

Shareholder Tools

menu_book Printed Materials
print Print
share Share

Subscribe to Investor Alerts

Sign up

Menu - Footer - Mobile Buttons

Contact Us Portals

6000 Shoreline Court, Suite 300
San Francisco, CA 94080

+1-650-243-6335

Menu - Footer - Contact Us

Contact Us

Connect:

Afirma
Genomic Sequencing Classifier
Decipher
Bladder Genomic Classifier
Decipher
Prostate Genomic Classifier
Prosigna
Breast Risk of Recurrence Test

Veracyte Diagnostics
Platform
Clinical Studies
Technology & Pipeline
Scientific Publications
Resource Center
Document Library
Portals

In the News
Press Releases
Events & Webinars

About Veracyte
Leadership
Careers
Investors
Blog
Corporate Recognition

© 2026 Veracyte, Inc. All rights reserved.

Instructions for Use
Safety Data Sheets
Privacy Notice
Accessibility

Terms of Use
Terms of Sale
No Surprises Act
Ethics & Compliance
Licenses & Certificates
Trademarks
Site Map

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.

Facebook
Twitter
LinkedIn